Safety and efficacy of weekly nab®-paclitaxel in combination with carboplatin as first-line therapy in elderly patients with advanced non-small-cell lung cancer

M. A. Socinski, C. J. Langer, I. Okamoto, J. K. Hon, V. Hirsh, S. R. Dakhil, R. D. Page, J. Orsini, H. Zhang, M. F. Renschler

Research output: Contribution to journalArticlepeer-review

96 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Safety and efficacy of weekly nab®-paclitaxel in combination with carboplatin as first-line therapy in elderly patients with advanced non-small-cell lung cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences